Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01335022 · ClinicalTrials.gov registry record · Early Phase 1
African American Community Health Project on Cardiovascular Disease
A Early Phase 1 study, sponsored by Northwestern University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 45
- Enrollment target
NCT01335022: Completed Early Phase 1 study, sponsored by Northwestern University.
NCT01335022 is a Early Phase 1 study that has completed, run by Northwestern University. The registered enrollment target is 45 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (15% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01335022, a Early Phase 1 study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 45 participants
- Enrollment target
Study Summary
The investigators seek to demonstrate that interactive physician-led education through partnership with an African American church will improve awareness and knowledge of cardiovascular disease in the African American community and will result in objective improvement in major risk factors associated with cardiovascular disease (CVD).
Primary Outcome
Change after educational series
Interventions
- BEHAVIORAL lecture
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2010-10 |
| Est. Completion | 2010-12 |
| Phase | Early Phase 1 |
What the finished NCT01335022 record still lists
NCT01335022 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (15% lower).
The record links to 0 conditions, and to 1 intervention - of which lecture is the first listed.
NCT01335022 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01335022 about?
NCT01335022 is a clinical study titled "African American Community Health Project on Cardiovascular Disease". The investigators seek to demonstrate that interactive physician-led education through partnership with an African American church will improve awareness and knowledge of cardiovascular disease in the African American community and will result in objective improvement in major risk factors associate...
What is the current status of trial NCT01335022?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 45 participants. The study started on 2010-10. Estimated completion is 2010-12.
What interventions are being tested in trial NCT01335022?
The interventions under investigation include: lecture (BEHAVIORAL).
Who is sponsoring clinical trial NCT01335022?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01335022's enrollment target sits among peer trials
45 575th of 2000 higher than 1,413 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia